Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Biochemistry and Cell Biology

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biocel.2010.02.005PMID 20156581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of small molecule inhibitors of pyruvate kinase M2.

  2010cited by this paper
• HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

  2010cited by this paper
• Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.

  2009cited by this paper
• Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis.

  2009cited by this paper
• A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines

  2009cited by this paper
• Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity.

  2009cited by this paper
• A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment.

  2009cited by this paper
• Differential Behavior of Missense Mutations in the Intersubunit Contact Domain of the Human Pyruvate Kinase M2 Isozyme*

  2009cited by this paper
• Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5‐fluorouracil resistance

  2009cited by this paper
• Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

  2009cited by this paper
• A survey of proteins encoded by non-synonymous single nucleotide polymorphisms reveals a significant fraction with altered stability and activity.

  2009cited by this paper
• The SUMO‐E3 ligase PIAS3 targets pyruvate kinase M2

  2009cited by this paper
• Isoform‐specific interaction of pyruvate kinase with hepatitis C virus NS5B

  2008cited by this paper
• Modulation of M2‐type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein

  2008cited by this paper
• Isotype‐specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation

  2008cited by this paper
• The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

  2008cited by this paper
• Oncogenes Meet Metabolism

  2008cited by this paper
• The Roles of PET and PET/CT in the Diagnosis and Management of Prostate Cancer

  2008cited by this paper
• Pyruvate kinase M2 is a phosphotyrosine-binding protein

  2008cited by this paper
• Nuclear Zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cells.

  2008cited by this paper
• Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.

  2008cited by this paper
• Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.

  2008cited by this paper
• Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling

  2008cited by this paper
• M2-PK as a novel marker in ovarian cancer. A prospective cohort study.

  2007cited by this paper
• Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death.

  2007cited by this paper
• Tumour M2-pyruvate kinase: a gastrointestinal cancer marker

  2007cited by this paper
• Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.

  2007cited by this paper
• Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.

  2007cited by this paper
• Regulation of Cell Proliferation by Interleukin-3-induced Nuclear Translocation of Pyruvate Kinase*

  2007cited by this paper
• Use of a novel method to find substrates of protein kinase C delta identifies M2 pyruvate kinase.

  2007cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.

  2007cited by this paper
• In vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRS.

  2007cited by this paper
• Science of cancer and aging.

  2007cited by this paper
• Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK.

  2006cited by this paper
• Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.

  2006cited by this paper
• Back to the roots: the remarkable RAF oncogene story

  2006cited by this paper
• Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.

  2006cited by this paper
• Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2]glucose reveals a heterogeneous metabolism in human leukemia T cells.

  2006cited by this paper
• Mitochondrial disorders in renal tumors.

  2006cited by this paper
• Pyrimidine pathways in health and disease.

  2005cited by this paper
• Tumor type M2 pyruvate kinase (TuM2‐PK) as a novel plasma tumor marker in melanoma

  2005cited by this paper
• Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.

  2005cited by this paper
• Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions.

  2005cited by this paper
• Pyruvate kinase type M2 and its role in tumor growth and spreading.

  2005cited by this paper
• Oxidative Phosphorylation Disease: Diagnosis and Pathogenesis

  2005cited by this paper
• Lactate: mirror and motor of tumor malignancy.

  2004cited by this paper
• Proteome analysis of hepatocellular carcinoma cell strains, MHCC97‐H and MHCC97‐L, with different metastasis potentials

  2004cited by this paper
• Loss of PKC-δ alters cardiac metabolism

  2004cited by this paper
• Evaluation of Myc E-Box Phylogenetic Footprints in Glycolytic Genes by Chromatin Immunoprecipitation Assays

  2004cited by this paper
• Decreased pyruvate kinase M2 activity linked to cisplatin resistance in human gastric carcinoma cell lines

  2004cited by this paper
• Phosphoglycerate Mutase-derived Polypeptide Inhibits Glycolytic Flux and Induces Cell Growth Arrest in Tumor Cell Lines*

  2004cited by this paper
• L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases

  2004cited by this paper
• Why do cancers have high aerobic glycolysis?

  2004cited by this paper
• Loss of PKC-delta alters cardiac metabolism.

  2004cited by this paper
• Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells

  2004cited by this paper
• Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2‐PK) as a tumor marker for cervical carcinoma

  2004cited by this paper
• The dual activity of pyruvate kinase type M2 from chromatin extracts of neoplastic cells.

  2003cited by this paper
• A multi-functional organelle mitochondrion is involved in cell death, proliferation and disease.

  2003cited by this paper
• Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence.

  2003cited by this paper
• Insulin Stimulates Expression of the Pyruvate Kinase M Gene in 3T3-L1 Adipocytes

  2003cited by this paper
• Interaction between HERC1 and M2‐type pyruvate kinase

  2003cited by this paper
• Regulation of glycolysis by Raf protein serine/threonine kinases.

  2002cited by this paper
• Cultivation in Glucose-Deprived Medium Stimulates Mitochondrial Biogenesis and Oxidative Metabolism in HepG2 Hepatoma Cells

  2002cited by this paper
• Pyruvate kinase type M2: a crossroad in the tumor metabolome

  2002cited by this paper
• The bioenergetic signature of cancer: a marker of tumor progression.

  2002cited by this paper
• Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.

  2002cited by this paper
• Papillomaviruses and cancer: from basic studies to clinical application

  2002cited by this paper
• Multisite control of the Crabtree effect in ascites hepatoma cells.

  2001cited by this paper
• Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: reversal by respiratory inhibitors.

  2001cited by this paper
• Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7

  2001cited by this paper
• Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.

  2001cited by this paper
• Potential Mechanisms for the Inhibition of Tumor Cell Growth by Manganese Superoxide Dismutase

  2001cited by this paper
• Tumor type M2 pyruvate kinase expression in advanced breast cancer.

  2000cited by this paper
• Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

  2000cited by this paper
• Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.

  2000cited by this paper
• Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats

  1999cited by this paper
• Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

  1999cited by this paper
• Nutrient and hormonal regulation of pyruvate kinase gene expression.

  1999cited by this paper
• Book Reviews

  1999cited by this paper
• Regulation of pyruvate kinase M gene expression.

  1999cited by this paper
• Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).

  1999cited by this paper
• Occurrence of the Crabtree effect in HeLa cells

  1998cited by this paper
• Expression of hypoxia-inducible genes in tumor cells

  1998cited by this paper
• Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools

  1998cited by this paper
• Oxidation of glutamine in HeLa cells: Role and control of truncated TCA cycles in tumour mitochondria

  1998cited by this paper
• Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?

  1998cited by this paper
• Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet.

  1998cited by this paper
• Role of PML in cell growth and the retinoic acid pathway.

  1998cited by this paper
• Hypoxia Regulates β-Enolase and Pyruvate Kinase-M Promoters by Modulating Sp1/Sp3 Binding to a Conserved GC Element*

  1998cited by this paper
• Using the yeast two‐hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth

  1998cited by this paper
• Metabolic characteristics of different malignant cancer cell lines.

  1998cited by this paper
• Low glutamine concentrations induce phenotypical and functional differentiation of U937 myelomonocytic cells.

  1997cited by this paper
• Glucose regulates the promoter activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1

  1997cited by this paper
• Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene.

  1997cited by this paper
• Effect of Extracellular AMP on Cell Proliferation and Metabolism of Breast Cancer Cell Lines with High and Low Glycolytic Rates*

  1997cited by this paper
• Alternative splicing of the pyruvate kinase M gene in a minigene system.

  1996cited by this paper
• p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins.

  1996cited by this paper
• Differences in DNA‐binding efficiency of Sp1 to aldolase and pyruvate kinase promoter correlate with altered redox states in resting and proliferating rat thymocytes

  1996cited by this paper
• Studies on associations of glycolytic and glutaminolytic enzymes in MCF‐7 cells: Role of P36

  1996cited by this paper

• The Perspectives of Posttranslational Modifications of Nuclear Proteins in Related Physiology and Diseases Assisted With Multi‐Omics Integrative Analysis and Machine Learning

  2026cites this paper
• The gene expression alterations in chronic hypoxic PANC-1 pancreatic cancer cell line

  2026cites this paper
• Proteomic analysis of fibroblasts exposed to Bis-GMA.

  2026cites this paper
• ¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis

  2026cites this paper
• Recent advances in novel targeting mechanisms for colorectal cancer

  2025cites this paper
• Centromere Protein F in Tumor Biology: Cancer's Achilles Heel

  2025cites this paper
• A review on the role of pyruvate kinase M2 in cancer: From metabolic switch to transcriptional regulation.

  2025cites this paper
• In Vitro Antibacterial and DPPH Radical Inhibitory Activities and In Silico Molecular Simulation of Compounds Isolated from the Leaves of Olinia rochetiana

  2025cites this paper
• Discovery of liquiritigenin derivatives as PKM2 allosteric inhibitors via targeting the polyarginine pocket.

  2025cites this paper
• Revisiting the Warburg Effect: Linking Hydrogen Sulfide to the Central Metabolic Network in Cancer

  2025cites this paper
• Targeting glucose-inhibited hippocampal CCK interneurons prevents cognitive impairment in diet-induced obesity.

  2025cites this paper
• Dual inhibition of oxidative phosphorylation and glycolysis using a hyaluronic acid nanoparticle NOX inhibitor enhanced response to radiotherapy in colorectal cancer.

  2025cites this paper
• A shift in PKM2 oligomeric state instructs adipocyte inflammatory potential

  2025cites this paper
• The effect of sulfamethoxazole on the performance of four types of constructed wetlands: Insights into microbial response characteristics, enzyme activities, and functional genes

  2025cites this paper
• Pyruvate kinase M2 activation maintains mitochondrial metabolism by regulating the interaction between HIF-1α and PGC-1α in diabetic kidney disease

  2025cites this paper
• SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling

  2025cites this paper
• Vascular smooth muscle cell metabolic reprogramming and phenotypic remodeling in atherosclerosis

  2025cites this paper
• The unusual metabolism of germinal center B cells.

  2025cites this paper
• Advances in the design and application of glycolysis-related nanodelivery systems for anti-tumor.

  2025cites this paper
• GSH as an A‐A Type Allosteric Activator of PKM2: Modulating Cancer Cell Homeostasis and Ferroptosis Susceptibility

  2025cites this paper
• PSD3, regulated by PKM2, endows growth and metastasis advantages in esophageal squamous cell carcinoma by modulating EMT progression

  2025cites this paper
• In vitro antibacterial activities, DPPH radical scavenging, and molecular simulation of isolated compounds from the stem bark of Grewia ferruginea

  2025influential citation
• Differential Regulation of PKM2, AMPK, and mTOR in Response to Insulin and Dietary Management

  2025cites this paper
• Pyruvate Kinase M2 Links Metabolism and Epigenetics: A New Target for Liver Disease Treatment

  2025cites this paper
• Molecular Pathway Modulation and Nanotechnology-Based Therapeutic Strategies for Shikonin.

  2025cites this paper
• Pyruvate kinase M2 modulates Japanese encephalitis virus replication in neuronal cells

  2025cites this paper
• IGFBP2 Promotes Proliferation and Glycolysis of Endometrial Cancer by Regulating PKM2/HIF‐1α Axis

  2025cites this paper
• YOD1 mediates isoproterenol-induced cardiac remodeling by deubiquitinating PKM2 and reducing PKM2 tetramerization in cardiomyocytes

  2025cites this paper
• Anti-M2-pyruvate kinase autoantibodies are correlated with digestive damage in human Chagas disease.

  2025cites this paper
• Transcriptomic profiling and biomarker discovery in pre-eclampsia: An integrated approach leveraging WGCNA and LASSO with ROC validation

  2025cites this paper
• Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

  2025cites this paper
• Deciphering enemy tactics – the narrow path to an optimal anti-cancer strategy targeting the Warburg effect

  2025cites this paper
• Pyruvate Kinase PKM2: Basic and Translational Aspects in Molecular Diagnosis of Human Malignancies

  2025influential citation
• The biology of PKM2 in the metabolism and senescence in diabetic kidney disease

  2025cites this paper
• In vitro antibacterial, DPPH radical scavenging activities, and in silico studies of isolated compounds from Rubus apetalus leaves extract

  2025cites this paper
• Halicin Reduces the Warburg Effect and Overcomes Drug Resistance by Activating the Pyruvate Kinase M2 Pathway for Triple-Negative Breast Cancer Treatment

  2025cites this paper
• Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies

  2025cites this paper
• Isoform-specific regulation of PKM by acetylation.

  2025cites this paper
• Novel Insight into The Warburg effect: Sweet Temptation.

  2025cites this paper
• Pyruvate Kinase M1/2 Proteoformics for Accurate Insights into Energy Metabolism Abnormity to Promote the Overall Management of Ovarian Cancer Towards Predictive, Preventive, and Personalized Medicine Approaches

  2025cites this paper
• Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator

  2025cites this paper
• CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models

  2025cites this paper
• S-Nitrosylation: Mechanistic Links between Nitric Oxide Signaling and Atherosclerosis

  2025cites this paper
• Design, Synthesis, and Molecular Docking of Quinazolines Bearing Caffeoyl Moiety for Targeting of PGK1/PKM2/STAT3 Signaling Pathway in the Human Breast Cancer.

  2024cites this paper
• Yinjia pills inhibits the malignant biological behavior of HeLa cells through PKM2-medicated inhibition of JAK/STAT3 pathway

  2024cites this paper
• In vitro antibacterial activities, DPPH radical scavenging, and molecular simulation of isolated compounds from the leaves of Rhus ruspolii

  2024cites this paper
• Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer

  2024cites this paper
• microRNA-1 Regulates Metabolic Flexibility in Skeletal Muscle via Pyruvate Metabolism

  2024cites this paper
• Aucklandiae radix targeted PKM2 to alleviate ulcerative colitis: Insights from the photocrosslinking target fishing technique.

  2024cites this paper
• The Use of Patient-Derived Organoids in the Study of Molecular Metabolic Adaptation in Breast Cancer

  2024cites this paper
• Glycolysis in gastrointestinal stromal tumor: a brief overview

  2024cites this paper
• Breast cancer cells utilize T3 to trigger proliferation through cellular Ca2+ modulation

  2024cites this paper
• Sepsis-induced changes in pyruvate metabolism: insights and potential therapeutic approaches

  2024cites this paper
• Splicing to orchestrate cell fate

  2024cites this paper
• Serine synthesis and catabolism in starved lung cancer and primary bronchial epithelial cells

  2024cites this paper
• Spectroscopic insights with molecular docking and molecular dynamic simulation studies of anticancer drug 5-Fluorouracil targeting human pyruvate kinase m2

  2024influential citation
• Imbalance in Glucose Metabolism Regulates the Transition of Microglia from Homeostasis to Disease-Associated Microglia Stage 1

  2024cites this paper
• PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer

  2024cites this paper
• Autophagy-related biomarkers in preeclampsia: the underlying mechanism, correlation to the immune microenvironment and drug screening

  2024cites this paper
• Regulatory Role of Autophagy and Glucose Metabolic Reprogramming in the Malignant Progression of Bladder Cancer: A Review

  2024cites this paper
• 1-Pyrroline-5-carboxylate inhibit T cell glycolysis in prostate cancer microenvironment by SHP1/PKM2/LDHB axis

  2024cites this paper
• PKM2 Activator TEPP-46 Suppresses Inflammation, Apoptosis, and Oxidative Disordering of Amyloid-Beta Treated Human Neuroblastoma

  2024cites this paper
• Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis

  2024cites this paper
• Tetramerization of pyruvate kinase M2 attenuates graft-versus-host disease by inhibition of Th1 and Th17 differentiation

  2024cites this paper
• The role of PI3K-Akt-mTOR axis in Warburg effect and its modification by specific protein kinase inhibitors in human and rat inflammatory macrophages.

  2024cites this paper
• The potential roles of PKM2 in cerebrovascular diseases.

  2024cites this paper
• The search for pyruvate kinase-R activators; from a HTS screening hit via an impurity to the discovery of a lead series.

  2024cites this paper
• Control of cyanobacterial growth with potassium; implications for bloom control in nuclear storage ponds.

  2024cites this paper
• Scutellarein treats neuroblastoma by regulating the expression of multiple targets

  2023cites this paper
• The potential role of T-cell metabolism-related molecules in chronic neuropathic pain after nerve injury: a narrative review

  2023cites this paper
• Evaluating the diagnostic and prognostic value of serum TuM2‐PK, NSE, and ProGRP in small cell lung cancer

  2023cites this paper
• Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma

  2023cites this paper
• Phytocompounds screening of Nigella sativa in terms of human cancer by targeting sphingosine kinase-1 and pyruvate kinase-M2: a study based on in silico analysis

  2023cites this paper
• Correlation of PKM2 Expression With HER2/neu and Additional Breast Cancer Biomarkers and its Prognostic Significance

  2023cites this paper
• The Role of PKM2 in Multiple Signaling Pathways Related to Neurological Diseases

  2023influential citation
• PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer

  2023cites this paper
• Interpretable attention-based deep learning ensemble for personalized ovarian cancer treatment without manual annotations

  2023cites this paper
• Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer

  2023cites this paper
• Phosphoglycerate dehydrogenase activates PKM2 to phosphorylate histone H3T11 and attenuate cellular senescence

  2023cites this paper
• Multifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma

  2023cites this paper
• [Shikonin induces hepatocellular carcinoma cell apoptosis by suppressing PKM2/PHD3/HIF-1α signaling pathway].

  2023cites this paper
• Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle.

  2023cites this paper
• The function of alternative splicing in the proteome: rewiring protein interactomes to put old functions into new contexts

  2023cites this paper
• Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance

  2023cites this paper
• The metabolic crosstalk between PIN1 and the tumour microenvironment.

  2023cites this paper
• Assessment of metabolic stability, pharmacokinetics by LC-MS/MS and establishment of safe dose of IMID-2, a novel anticancer molecule under drug discovery.

  2023cites this paper
• Knockdown of pyruvate kinase M2 suppresses bladder cancer progression

  2023cites this paper
• In-depth insight into improvement of simultaneous nitrification and denitrification/biofouling control by increasing sludge concentration in membrane reactor: performance, microbial assembly and metagenomic analysis.

  2023cites this paper
• An insight into the structure-activity relationship studies of anticancer medicinal attributes of 7-azaindole derivatives: a review.

  2023cites this paper
• Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma

  2023cites this paper
• Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors

  2023cites this paper
• PKM2 controls the translation of TFE3 to maintain the integrity of the Golgi apparatus for the survival of HeLa and ME‐180 cervical cancer cells

  2023cites this paper
• OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer

  2023cites this paper
• Potential therapies targeting nuclear metabolic regulation in cancer

  2023cites this paper
• Pyruvate Kinase Activity Regulates Cystine Starvation Induced Ferroptosis through Malic Enzyme 1 in Pancreatic Cancer Cells

  2023cites this paper
• PTP4A1 promotes oral squamous cell carcinoma (OSCC) metastasis through altered mitochondrial metabolic reprogramming

  2023cites this paper
• Metabolic targeting of platelets to combat thrombosis: dawn of a new paradigm?

  2023cites this paper
• Protein-Metabolite Interactions Shape Cellular Metabolism and Physiology.

  2023cites this paper
• An intricate rewiring of cancer metabolism via alternative splicing.

  2023cites this paper
• Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2

  2023cites this paper